UCLA Longevity Center
Welcome,         Profile    Billing    Logout  
 3 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Small, Gary W
CANTORSING, NCT05427084: Canagliflozin Targeting Vascular Inflammation

Recruiting
2/3
24
Canada
Canagliflozin, Invokana, Placebo
Ottawa Heart Institute Research Corporation
Diabetes Type 2, Coronary Artery Disease
12/25
12/26
Merrill, David
QUIP II, NCT06025877: Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey

Recruiting
N/A
400
US
PrecivityAD2(TM) blood test, AD2
C2N Diagnostics
Alzheimer Disease, Mild Cognitive Impairment, Dementia, Cognitive Decline, Cognitive Impairment, Memory Impairment
04/25
04/25
McEwen, Sarah
CT&E-RCT, NCT02823041: Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode

Completed
N/A
100
US
Cognitive Training, cognitive remediation, Aerobic Exercise, physical exercise, Case management and supportive psychotherapy, Individual Placement and Support, supported education/employment
University of California, Los Angeles
Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder
06/23
06/23
Rosensteel, Anya
No trials found

Download Options